Ozlem Ozdemir Isik

Ozlem Ozdemir Isik

Auto-generated profile, based on publicly available information

Ozlem Ozdemir Isik

Division of Rheumatology, Department of Internal Medicine, School of Medicine, Kocaeli University, Kocaeli, Turkey

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2022 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
MZMahbuba Zahid
Mahbuba Zahid
EÜEdibe Ünal
Edibe Ünal
ÖIÖzlem Özdemir Işık
Özlem Özdemir Işık
SOSevim Oksuz
Sevim Oksuz
JKJale Karakaya
Jale Karakaya
ACAyse Erguney Cefle
Ayse Erguney Cefle

1 January 2021 in International Journal Of Clinical Practice
Verified
Journal Article
Closed access
PDF file
AYAyten Yazici
Ayten Yazici
OIOzlem Ozdemir Isik
Ozlem Ozdemir Isik
DKDuygu Temiz Karadag
Duygu Temiz Karadag
ACAyse Cefle
Ayse Cefle
Objective Familial Mediterranean Fever (FMF) is an autoinflammatory disease that is commonly present with recurrent episodes of fever, peritonitis, pleuritis or arthritis. Enthesitis and sacroilitis can also be seen in FMF. Spondylitis is a less common manifestation of joint involvement in FMF and there are controversial publications about whether this involvement is FMF-related or coincidentally. The aim of this study was to provide a comparison between ankylosing spondylitis (AS) patients and FMF patients with AS. Methods A total of 404 patients who 360 of them was AS and 44 was FMF patients with AS (in accordance with Tel Hashomer) patients with AS (in accordance with modified New York criteria) were included in this study. All cases were evaluated retrospectively and patient's demographic and clinical data were recorded. Results The mean age was 34.5 +/- 8.6 years and 61.4% of patients were female in FMF group. In AS group, the mean age was 41.2 +/- 10.8 years and 67.8% of patients were male. In AS group, 92% of patients had inflammatory back pain, 51% had hip pain, 30% had heel pain, 14% had peripheral arthritis and 11% had uveitis. In FMF group, 98% of patients had inflammatory back pain, 59% had hip pain, 48% had heel pain, 43% had peripheral arthritis and 4.5% had uveitis. Syndesmophyte and enthesitis on X-ray were seen in 18% and 22% of AS patients, and 7% and 41% of FMF patients with AS, respectively. There were significant differences between AS patients and FMF patients with AS in terms of heel pain (P: .017), peripheral arthritis (P: .000) and enthesitis (P: .006). Conclusion Peripheral arthritis and enthesitis were more frequent, and uveitis and syndesmophyte were less frequent in FMF patients with spondylitis than AS patients. When we look at gender differences, clinical and genetic features, it seems to be different condition from AS.

25 April 2019 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
DKDuygu Temiz Karadag
Duygu Temiz Karadag
TSTayfun Sahin
Tayfun Sahin
STSenem Tekeoglu
Senem Tekeoglu
OIOzlem Ozdemir Isik
Ozlem Ozdemir Isik
AYAyten Yazici
Ayten Yazici
ACAyse Cefle
Ayse Cefle

1 January 2022 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
PDF file
ÖIÖzlem Özdemi̇r Işik
Özlem Özdemi̇r Işik
AYAyten Yazici
Ayten Yazici
AÇAyşe Çefle
Ayşe Çefle
Background/aim: Sjögren?s syndrome is a systemic, autoimmune disease and can affect many organs and systems. In this study, we aimed to evaluate the respiratory manifestations, and the association between interstitial lung disease (ILD) and disease activity in primary SS (pSS) patients. Materials and methods: The study design was retrospective cross-sectional, and 151 patients followed up with a diagnosis of pSS between 2004 and 2019 were included in the study. Demographic and clinical data, laboratory results, chest radiographs and thorax computed tomography (CT) results were obtained from patient files and hospital imaging system. Thorax CT was requested from all patients with respiratory complaints and abnormalities in physical examination and pulmonary function test. Disease activity was calculated with EULAR pSS disease activity index (ESSDAI) and clinical European League Against Rheumatism SS Disease Activity Index (clin-ESSDAI). Results: In our study, 97% of pSS patients were female, and the mean age was 55.9 ± 12 years, disease onset age was 45.5 ± 12.1 years, disease duration was 10.7 (1?38) years. According to CT findings of 120 patients, 35% had nodules, and 13.3% had ILD (62.5% nonspecific interstitial pneumonia, 25% lymphocytic interstitial pneumonia, 12.5% usual interstitial pneumonia). Bronchiectasis, emphysema, sequelae fibrotic changes, and pleural thickening was found in 3.3%, 5.8%, 15.8%, and 1.7% of patients, respectively. It was observed that there was a significant relationship between the presence of ILD and persistent cough, mediastinal LAP, low DLCO, high ESSDAI and clin-ESSDAI scores reflecting disease activity. Conclusion: The most common pulmonary manifestation in our patients was ILD. ILD was observed more frequently in patients with moderate and severe disease activity. Some of the ILD patients were diagnosed while they were asymptomatic. Even if they are asymptomatic, it is important to follow up the patients with physical examination, spirometry, DLCO and thorax CT.

15 February 2024 in The Journal of Sexual Medicine
Verified
Journal Article
Open access
OIOzlem Ozdemir Isik
Ozlem Ozdemir Isik
DKDuygu Temiz Karadag
Duygu Temiz Karadag
STSenem Tekeoglu
Senem Tekeoglu
AYAyten Yazici
Ayten Yazici
ACAyse Cefle
Ayse Cefle
Background: Sjögren’s syndrome (SS) is an autoimmune systemic disease affecting many organs and systems, such as genital system. Aim: This study aimed to present the gynecological symptoms of patients who were followed up in an outpatient clinic because of primary Sjögren’s syndrome (pSS) and secondary Sjögren’s syndrome (sSS) and to show how the disease affected sexuality. Methods: This study is a cross-sectional study conducted between 2019 and 2020. The study sample consisted of 60 pSS patients, 42 sSS patients, and 52 healthy control subjects. Outcomes: All the participants were questioned about sexuality, and completed the 36-item Short Form Survey, Hospital Anxiety and Depression Scale, Health Assessment Questionnaire, and Modified Hill questionnaire. Results: The patients had a mean age of 55.6 ± 11.85 years in pSS, 59.39 ± 11.18 years in sSS, and 56.1 ± 10.46 years in healthy control subjects. Vaginal and vulvar dryness and dyspareunia were present at a significantly higher rate in SS, especially in pSS, compared with the control subjects. The Health Assessment Questionnaire score was significantly lower in the pSS group than in the sSS group. Arthralgia, myalgia, and fatigue were prominent in all SS patients. Clinical Implications: Gynecological symptoms, sexual ability, and the effects of the disease on sexuality should be questioned in all SS patients. Strengths and Limitations: It is very important that we evaluate the gynecological symptoms of both pSS and sSS patients and the effect of the disease on these symptoms. The small number of patients and healthy control subjects is a limitation. Conclusion: The gynecological and musculoskeletal symptoms negatively affected sexuality in patients with pSS and sSS, and the negative effect of the disease on sexuality was more pronounced in the pSS group.

31 January 2025 in Rheumatology International
Verified
Journal Article
Open access
PDF file
NGNeslihan Gokcen
Neslihan Gokcen
AKAndac Komac
Andac Komac
FKFatma Tuncer Kuru
Fatma Tuncer Kuru
OIOzlem Ozdemir Isik
Ozlem Ozdemir Isik
DKDuygu Temiz Karadag
Duygu Temiz Karadag
ACAyse Cefle
Ayse Cefle
This study aims to investigate the relationship between sleep hygiene and sleep quality in patients with systemic sclerosis (SSc) and to compare the sleep hygiene and sleep quality outcomes across three distinct groups: SSc patients, rheumatoid arthritis (RA) patients, and healthy controls (HC). This study employed an observational, cross-sectional, and parallel group design. SSc-related and RA-related variables, depression and anxiety were assessed. Physical function and quality of life, pain and fatigue of SSc patients were also evaluated. Sleep quality using the Pittsburg Sleep Quality Index (PSQI) and sleep hygiene using the Sleep Hygiene Index (SHI) were evaluated for all participants. Linear regression analysis was performed to show the relationship between the SHI scores and the other variables. Total PSQI and SHI scores were found to be significantly higher in SSc patients than in RA patients and HC. Fatigue, smoking, all SF-36 domains, depression and anxiety scores were associated with SHI scores in SSc patients. In the univariate logistic regression analysis, SSc patients exhibited 4.50 times higher odds (95% CI 2.165–9.353, p < 0.001) of experiencing poor sleep than RA patients and HC. In SSc patients, for every incremental increase in SHI score, the odds of poor sleep quality were 1.15 times higher (95% CI 1.093–1.220, p < 0.001). Sleep hygiene and sleep quality exhibit a more pronounced deterioration in SSc patients. Inadequate sleep hygiene is associated with compromised sleep quality in SSc. Therefore, improving sleep hygiene practices may be a key strategy to enhance the overall sleep quality in this population.